Circulating levels of clusterin and complement factor H in patients with obstructive sleep apnea

Biomark Med. 2021 Apr;15(5):323-330. doi: 10.2217/bmm-2020-0533. Epub 2021 Mar 5.

Abstract

Aim: Obstructive sleep apnea (OSA) activates the complement system; however, the levels of membrane attack complex (MAC) are unaltered suggesting regulatory mechanisms. Our aim was to investigate complement factor H (CFH) and clusterin, two important complement regulators in OSA. Materials & methods: We analyzed clusterin and CFH levels in plasma of 86 patients with OSA and 33 control subjects. Results: There was no difference in CFH levels between patients (1099.4/784.6-1570.5/μg/ml) and controls (1051.4/652.0-1615.1/μg/ml, p = 0.72). Clusterin levels were higher in patients with OSA (309.7/217.2-763.2/μg/ml vs 276.1/131.0-424.3/μg/ml, p = 0.048) with a trend for a positive correlation with disease severity (p = 0.073). Conclusion: Increase in clusterin levels may be protective in OSA by blocking the MAC formation.

Keywords: OSA; complement system; inflammation; sleep apnea.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood*
  • Case-Control Studies
  • Clusterin / blood*
  • Complement Factor H / metabolism
  • Female
  • Humans
  • Male
  • Middle Aged
  • Sleep Apnea, Obstructive / blood
  • Sleep Apnea, Obstructive / diagnosis*
  • Sleep Apnea, Obstructive / epidemiology
  • United Kingdom / epidemiology

Substances

  • Biomarkers
  • CFH protein, human
  • CLU protein, human
  • Clusterin
  • Complement Factor H